GEODE CAPITAL MANAGEMENT, LLC
Position in DNA — Ginkgo Bioworks Holdings, Inc.
CIK 1214717
BOSTON, MA
Position in DNA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,110,177
+$5,922,789 QoQ
Shares Held
1,222,016
+21.1% QoQ
Ownership
1.81%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 183 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. DNA ranks #174 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in DNA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,110,177 | 1,222,016 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $6,187,388 | 1,009,362 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,306,675 | 999,600 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $11,785,888 | 808,360 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $10,547,808 | 937,583 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,613,044 | 458,429 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,291,585 | 437,025 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,395,541 | 416,631 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $5,114,297 | 15,312,270 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $25,393,055 | 21,890,565 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $35,638,468 | 21,087,851 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $36,269,940 | 20,038,641 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $32,233,204 | 17,329,680 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $18,202,906 | 13,686,396 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $19,899,841 | 11,775,054 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $31,418,618 | 10,070,070 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $28,609,361 | 12,020,740 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $39,493,613 | 9,799,904 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $81,143,019 | 9,764,503 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||